|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1996-6-20
|
|
pubmed:abstractText |
The prognosis of patients with locally advanced esophageal cancer (LAEC) remains poor when treated with local modalities. An intensive preoperative program with chemoradiotherapy was used to evaluate the curative resection rate, pathologic response, and survival of patients with LAEC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BreuerNN,
pubmed-author:EGANJ PJP,
pubmed-author:EiglerF WFW,
pubmed-author:FettWW,
pubmed-author:MakoskiH BHB,
pubmed-author:MollsMM,
pubmed-author:NiebelWW,
pubmed-author:SackHH,
pubmed-author:SchmidtUU,
pubmed-author:SeeberSS,
pubmed-author:SiewertJ RJR,
pubmed-author:StahlMM,
pubmed-author:StuschkeMM,
pubmed-author:WalzM KMK,
pubmed-author:WilkeHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
829-37
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8622031-Adenocarcinoma,
pubmed-meshheading:8622031-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8622031-Carcinoma,
pubmed-meshheading:8622031-Carcinoma, Squamous Cell,
pubmed-meshheading:8622031-Cause of Death,
pubmed-meshheading:8622031-Cisplatin,
pubmed-meshheading:8622031-Combined Modality Therapy,
pubmed-meshheading:8622031-Esophageal Neoplasms,
pubmed-meshheading:8622031-Etoposide,
pubmed-meshheading:8622031-Female,
pubmed-meshheading:8622031-Fluorouracil,
pubmed-meshheading:8622031-Humans,
pubmed-meshheading:8622031-Leucovorin,
pubmed-meshheading:8622031-Male,
pubmed-meshheading:8622031-Preoperative Care,
pubmed-meshheading:8622031-Survival Analysis,
pubmed-meshheading:8622031-Treatment Failure
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial.
|
|
pubmed:affiliation |
Department of Internal Medicine (Cancer Research), Essen University Medical School, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
